BRIEF-Qualigen Therapeutics, Inc. Receives Expected Notification Of Deficiency From Nasdaq Related To Delayed Filing Of Quarterly Report On Form 10-Q

Reuters
20 May
BRIEF-<a href="https://laohu8.com/S/QLGN">Qualigen Therapeutics, Inc.</a> Receives Expected Notification Of Deficiency From Nasdaq Related To Delayed Filing Of Quarterly Report On Form 10-Q

Qualigen Therapeutics Inc QLGN.O:

  • QUALIGEN THERAPEUTICS, INC. RECEIVES EXPECTED NOTIFICATION OF DEFICIENCY FROM NASDAQ RELATED TO DELAYED FILING OF QUARTERLY REPORT ON FORM 10-Q

Source text: ID:nGNX2CH3B6

Further company coverage: QLGN.O

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10